liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Pulmonell hypertension vanligt vid kronisk lungsjukdom - Europeiska riktlinjer kring utredning och behandling
Region Östergötland, Heart and Medicine Center, Department of Clinical Physiology in Linköping.
Sektionen för Hjärtsvikt och klaffsjukdomar, Hjärt- och lungkliniken SUS Lund, Sweden.
2017 (Swedish)In: Läkartidningen, ISSN 0023-7205, E-ISSN 1652-7518, Vol. 114Article, review/survey (Refereed) Published
Abstract [en]

Pulmonary hypertension due to lung diseases In 2015 the European Society of Cardiology and European Respiratory Society published new guidelines on the diagnosis and treatment of pulmonary hypertension (PH). PH due to lung diseases and/or hypoxia was classified as a separate entity. PH is common in lung diseases, but seldom severe. Nevertheless, the presence of PH in a patient with lung disease is associated with worse outcome. If there is clinical suspicion of PH in a patient with lung disease, echocardiography is recommended, and if there are signs of severe PH and/or severe right ventricular dysfunction the patient should be referred to a PH expert centre. Patients may have lung disease and e.g. pulmonary arterial hypertension or chronic thromboembolic PH simultaneously, and targeted treatments are available in such cases. PH-targeted drugs should, however, not be used to treat PH due to lung diseases, since there are no robust data speaking for their benefit and a risk of impaired arterial oxygenation due to inhibition of hypoxic pulmonary vasoconstriction. Instead, the underlying lung disease should be optimally treated, including long-term oxygen therapy in case of chronic hypoxemia.

Place, publisher, year, edition, pages
2017. Vol. 114
National Category
Cardiac and Cardiovascular Systems Respiratory Medicine and Allergy
Identifiers
URN: urn:nbn:se:liu:diva-146299PubMedID: 28742187OAI: oai:DiVA.org:liu-146299DiVA, id: diva2:1195932
Available from: 2018-04-07 Created: 2018-04-07 Last updated: 2018-04-07

Open Access in DiVA

No full text in DiVA

PubMed

Search in DiVA

By author/editor
Kylhammar, David
By organisation
Department of Clinical Physiology in Linköping
In the same journal
Läkartidningen
Cardiac and Cardiovascular SystemsRespiratory Medicine and Allergy

Search outside of DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric score

pubmed
urn-nbn
Total: 99 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf